BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kan WC, Chen YC, Wu VC, Shiao CC. Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application. Int J Mol Sci 2022;23:2052. [PMID: 35216167 DOI: 10.3390/ijms23042052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mu F, Cui C, Tang M, Guo G, Zhang H, Ge J, Bai Y, Zhao J, Cao S, Wang J, Guan Y. Analysis of a machine learning–based risk stratification scheme for acute kidney injury in vancomycin. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1027230] [Reference Citation Analysis]
2 Liu H, Yang H, Guo X, Bai Y, Siri G. Clinical benefits of therapeutic drug monitoring of vancomycin therapy in patients with postoperative intracerebral hemorrhage: a retrospective cohort study. Eur J Hosp Pharm 2022. [DOI: 10.1136/ejhpharm-2022-003455] [Reference Citation Analysis]
3 Laou E, Mavridis T, Papagiannakis N, Pais G, Chighine A, Chang J, Locci E, D’aloja E, Scheetz M, Chalkias A, Xanthos T. Blood Biomarkers and Metabolomic Profiling for the Early Diagnosis of Vancomycin-Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis of Experimental Studies. JPM 2022;12:1397. [DOI: 10.3390/jpm12091397] [Reference Citation Analysis]
4 Lee S, Jung S, Kim MJ, Lee JS, Jang HN, Chang SH, Kim HJ. Clinical and histopathological analyses of kidney biopsies in a single center for 7 years. Medicine (Baltimore) 2022;101:e29695. [PMID: 35866761 DOI: 10.1097/MD.0000000000029695] [Reference Citation Analysis]
5 Briscese K, Yuan M, Hong TS, Brunetti L. Natural products for the prevention of antibiotic-associated kidney injury. Current Opinion in Toxicology 2022. [DOI: 10.1016/j.cotox.2022.100363] [Reference Citation Analysis]